Stool Softener Tablet
NDC Package 57896-421-01
Package Information
Stool Softener (docusate sodium) tablets is a medication used to treat occasional constipation. This formulation utilizes a tablet delivery system. Marketed by Geri-care Pharmaceuticals, Corp, this product is identified by NDC 57896-421 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 1099279 - docusate sodium 100 MG Oral Tablet
- RxCUI: 1099279 - DOSS Sodium 100 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57896 - Geri-care Pharmaceuticals, Corp
- 57896-421 - Stool Softener
- 57896-421-01 - 100 TABLET in 1 BOTTLE
- 57896-421 - Stool Softener
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (57896-421). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57896-421-01 identifies a specific commercial package of 100 tablet in 1 bottle of Stool Softener, a human over the counter drug labeled by Geri-care Pharmaceuticals, Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains docusate sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-care Pharmaceuticals, Corp on September 01, 2015. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat occasional constipation. Some medications and conditions can make constipation more likely. Stool softeners such as docusate are often the first method used for preventing and treating this type of constipation. Docusate is often used when straining to have a bowel movement should be avoided (e.g., after a heart attack or surgery). Docusate is a stool softener. It works by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass.
How is this Geri-care Pharmaceuticals, Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896042101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.